Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM, Dekkers OM, Pieterman CR, Kluijfhout WP, Hermus AR, Pereira AM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, de Herder WW, Valk GD. J Clin Endocrinol Metab. 2015 Sep;100(9):3288-96. doi: 10.1210/JC.2015-2015. PMID: 26126205 https://www.ncbi.nlm.nih.gov/pubmed/26126205
Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d’étude des Tumeurs Endocrines (GTE) retrospective study.
Vezzosi D, Cardot-Bauters C, Bouscaren N, Lebras M, Bertholon-Grégoire M, Niccoli P, Levy-Bohbot N, Groussin L, Bouchard P, Tabarin A, Chanson P, Lecomte P, Guilhem I, Carrere N, Mirallié E, Pattou F, Peix JL, Goere D, Borson-Chazot F, Caron P, Bongard V, Carnaille B, Goudet P, Baudin E. Eur J
A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
Tonelli F, Giudici F, Giusti F, Marini F, Cianferotti L, Nesi G, Brandi ML (2014). EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol. 171; p. K7-K17, ISSN: 0804-4643, doi: 10.1530/EJE-14-0080 https://www.ncbi.nlm.nih.gov/pubmed/24819502 Free PMC Article
Sarcomatoid carcinoma of the kidney in a MEN1 patient: Case report and genetic profile.
Cavalli T, Giudici F, Nesi G, Marini F, Giusti F, Cavalli L, Brandi ML, Tonelli F (2014). ENDOCRINE JOURNAL, ISSN: 0918-8959 https://www.ncbi.nlm.nih.gov/pubmed/24882518 Free PMC Article
Hereditary hyperparathyroidism syndromes.
Giusti F, L. Cavalli, T. Cavalli, M.L. Brandi (2013). JOURNAL OF CLINICAL DENSITOMETRY, vol. 16; p. 69-74, ISSN: 1094-6950, doi: 10.1016/j.jocd.2012.11.003 https://www.ncbi.nlm.nih.gov/pubmed/23374744
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the “Knudson’s second hit”.
Luzi, F. Marini, Giusti F, G. Galli, L. Cavalli, M.L. Brandi (2012). PLOS ONE, vol. 7; p. e39767-e39767, ISSN: 1932-6203, doi: 10.1371/journal.pone.0039767 https://www.ncbi.nlm.nih.gov/pubmed/22761894 Free PMC Article
Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Francesco Tonelli, Francesco Giudici, Giusti F, Maria Luisa Brandi (2012). CANCERS, vol. 4; p. 504-522, ISSN: 2072-6694, doi: 10.3390/cancers4020504 https://www.ncbi.nlm.nih.gov/pubmed/24213321 Free PMC Article
Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?.
Giusti F, F. Tonelli, M.L. Brandi (2012). CLINICS, vol. 67 Suppl 1; p. 141-144, ISSN: 1807-5932 https://www.ncbi.nlm.nih.gov/pubmed/22584719 Free PMC Article
Update multiple endocrine neoplasia type 2
Raue F1, Frank-Raue K. Fam Cancer. 2010 Sep;9(3):449-57. doi: 10.1007/s10689-010-9320-2. https://www.ncbi.nlm.nih.gov/pubmed/20087666
Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
J. Moyes, J. P. Monson, S. L. Chew, S. A. Akker Int J Endocrinol. 2010; 2010: 906163. Published online 2010 May 26. doi: 10.1155/2010/906163 PMCID: PMC2877200 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877200/
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Ambrosini V1, Campana D, Bodei L, Nanni C, Castellucci P, Allegri V, Montini GC, Tomassetti P, Paganelli G, Fanti S. J Nucl Med. 2010 May;51(5):669-73. doi: 10.2967/jnumed.109.071712. https://www.ncbi.nlm.nih.gov/pubmed/20395323
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.
Appetecchia M1, Baldelli R. J Exp Clin Cancer Res. 2010 Mar 2;29:19. doi: 10.1186/1756-9966-29-19. https://www.ncbi.nlm.nih.gov/pubmed/20196864
